Grant

Grant RDF

pages:

Pediatric Eye Disease Investigator Group
Pediatric Eye Disease Investigator Group - MTS1
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching Vs Atropine For Amblyopia In 7 To <13 Years Olds - Amblyopia Treatment Study 9 (Ancillary Study)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Second Eye as Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old (ATS 8)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old (ATS 6)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Years Olds (ATS-9)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching with Active Vision Therapy to Patching with Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old (Feasibility Phase) - Amblyopia Treatment Study A12
Pediatric Eye Disease Investigator Group: A Randomized Trial of Full-Time Bangerter Filters Versus Part-Time Daily Patching for the Treatment of Moderate Amblyopia in Children - Amblyopia Treatment Study 10
Pediatric Eye Disease Investigator Group: A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old (ATS-5)
Pediatric Eye Disease Investigator Group: A Randomized Trial to Evaluate 8 Hours of Daily Patching Plus Daily Atropine for Rsidual Amblyopia in Children 3 to <8 Years Old - Amblyopia Treatment Study 11
Pediatric Eye Disease Investigator Group: Administrative Core
Pediatric Eye Disease Investigator Group: An Evaluation of Treatment of Amblyopia in Children 7 to <18 Years Old (ATS-3)
Pediatric Eye Disease Investigator Group: An Observational Study of Optical Correction for Strabismis Amblyopia in Children 3 to <7 Years Old - Amblyopia Treatment Study 13
Pediatric Eye Disease Investigator Group: Augmenting Atropine Treatment for Amblyopia (ATS 16)
Pediatric Eye Disease Investigator Group: Bilateral Refractive Amblyopia Treatment Study (ATS-7)
Pediatric Eye Disease Investigator Group: Correction of Refractive Error for Amblyopia Protocol (XO1)
Pediatric Eye Disease Investigator Group: Increasing Patching for Amblyopia (ATS15)
Pediatric Eye Disease Investigator Group: Intermittent Exotropia Study 2 (IXT2): A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia
Pediatric Health Information Line Train the Trainer: Telephone Advice for Families in Asthma Management
Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC) [AMP]
Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC) [SMARTT]
Pediatric HIV/AIDS Cohort Study (PHACS): 2020, AMP Up Series
Pediatric HIV/AIDS Cohort Study (PHACS): 2020, SMARTT
Pediatric Hydroxyurea Phase III Clinical Trial: Baby Hug
Pediatric Injuries During COVID Epidemic Study
Pediatric Intravenous Versus Oral Antibiotic Therapy
Pediatric Mental Health Access Grant
Pediatric MS Network
Pediatric Oncology COVID Cancer Case Report - A National Registry of Children with Cancer (POCC)
Pediatric Palliative Care Research Network SHARE Study

pages: